Clinical Trial Update: Study of OP-1 Putty in Uninstrumented Posterolateral Fusions

View source ↗

Summary

The clinical trial evaluating OP-1 Putty for uninstrumented posterolateral fusion in degenerative lumbar spondylolisthesis has completed. The sponsor listed is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Lumbar Spondylolisthesis

Drugs mentioned

• OP-1 Putty (recombinant human osteogenic protein-1 (OP-1) putty)

Snippet

Sponsor: Olympus Biotech Corporation | Conditions: Degenerative Lumbar Spondylolisthesis | Status: COMPLETED